Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 28, 2005; 11(20): 3131-3134
Published online May 28, 2005. doi: 10.3748/wjg.v11.i20.3131
Table 1 Primers and probes for detections of G1896A or A1762T/G1764A mutations.
DenominationSequences (5’-3’)
PCPBIO -GAGAC TCTAA GGCTT CTCGA TACAG AGCTG AGG
PCMdDIG -CTCAC GCTAC ATTGT GTGCC TTGGG TGGCT TCA
PCWdFITC -GTCCG TAGTC TCGTT GTGCC TTGGG TGGCT TGG
BCP1-MDIG -GCTGA CGATG CGATG GGGAG GAGAT TAGGT TAATG A-3’
BCP1-WFITC -CGTCC GTAGT GCCGA GGGAG GAGAT TAGGT TAAAG G-3’
PCACCCAG CAGAG AATGG CTTGC CTGAG TGCAG TATG
PCScCCCGA ATTCC ACCGT GAACG CCCAT CAG
PCAcCCCAA GCTTG CAGTA TGGTG AGGTG AGCAA TG
Table 2 Relationship between CD-PCR results and serum HBV DNA load in 165 serum samples with detectable HBV DNA in serum after HBeAg-to-anti-HBe seroconversion.
No. (%) of CD-PCR results
Total G1896ATotal A1762T/G1764AG1896A onlyA1762T/G1764A onlyCoexistence
Low-level group (n = 61)53 (86.9)b20 (32.8)35 (57.4)d2 ( 3.3)18 (29.5)
Median level group (n = 58)45 (77.6)32 (55.2)e23 (39.6)10 (17.3)22 (37.9)
High-level group (n = 46)30 (65.2)31 (67.4)f6 (13.0)7 (15.2)24 (52.2)g
Table 3 Main clinical data of 147 serum samples with G1896A and/or A1762T/G1764A mutations.
G1896A only (n = 64)A1762T/G1764A only (n = 19)Coexistence (n = 64)
Age (yr)40.5±12.843.2±14.240.7±12.8
Sex (no. male/no. female)55/918/1May-59
Alanine aminotransferase (IU/L)101.9±158.3121.8±183.1116.7±137.3
Total bilirubin (mmol/L)25.2±39.224.8±40.632.5±55.2b
Serum albumin (g/L)38.4±5.339.1±5.837.7±5.3d
Clinical diagnosis
Chronic hepatitis Mild (n)23313
Median (n)201014
Gravies (n)12422f
Liver cirrhosis9215g